Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Digest.
Press releases published on April 1, 2025
Meeting-Seeking Wildfire Claim to Insurance Company CEO: "I Speak With God Every Day! Why Can't I Speak With You?"
EIN Presswire
·
April 1, 2025
Poignant words from Nurse Pamela Jane Nye after unsuccessful CEO meeting contact attempts to timely resolve Nye's denied Palisades wildfire insurance claim. PACIFIC PALISADES, CA, UNITED STATES, April 1, 2025 /EINPresswire.com/ -- After the Pacific …
TOKEN2049 Dubai: 30 Days to Go – On Track to Sell Out Amid Record-Breaking Demand
EIN Presswire
·
April 1, 2025
TOKEN2049 Dubai will take place at Madinat Jumeirah from 30 April-1 May, bringing together 15,000 attendees from across the globe for an unparalleled experience DUBAI, UNITED ARAB EMIRATES, April 1, 2025 /EINPresswire.com/ -- This time next month, …
COSCIENS Biopharma Inc. Announces Receipt of Management Cease Trade Order
GlobeNewswire
·
April 1, 2025
TORONTO, ONTARIO, April 01, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX: CSCI) (“COSCIENS” or the “Company”), a life science company which develops and commercializes a diversified portfolio of cosmeceutical, nutraceutical and …
Ero Copper to Release First Quarter 2025 Operating and Financial Results on May 5, 2025
GlobeNewswire
·
April 1, 2025
VANCOUVER, British Columbia, April 01, 2025 (GLOBE NEWSWIRE) -- Ero Copper Corp. (TSX: ERO, NYSE: ERO) (the “Company”) will publish its first quarter 2025 operating and financial results on Monday, May 5, 2025, after market close. The Company will host a …
Polyrizon Ltd. Announces Closing of $17.0 Million Private Placement
GlobeNewswire
·
April 1, 2025
RAANANA, ISRAEL, April 01, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (NASDAQ: PLRZ) (the “Company”), a biotech company specializing in innovative intranasal hydrogels, today announced the closing of its previously announce private placement of approximately …
Revolution Medicines to Deliver Multiple Presentations at the 2025 American Association for Cancer Research (AACR) Annual Meeting
GlobeNewswire
·
April 1, 2025
REDWOOD CITY, Calif., April 01, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced 11 oral and poster …
JustMarkets Is a Diamond Sponsor at Money Expo Abu Dhabi 2025
EIN Presswire
·
April 1, 2025
RIYADH, SAUDI ARABIA, April 1, 2025 /EINPresswire.com/ -- JustMarkets, a global leader in online trading, is proud to announce its participation as a Diamond Sponsor at Money Expo 2025, which will be held on 23-24 April 2025 at Conrad Abu Dhabi, Etihad …
Endeavour Silver Increases Previously Announced Bought Deal Financing to US$45 Million
GlobeNewswire
·
April 1, 2025
The Base Shelf Prospectus is accessible, and the Prospectus Supplement will be accessible within two business days, through SEDAR+ All dollar amounts are stated in United States (U.S.) Dollars unless otherwise noted. VANCOUVER, British Columbia, April 01, …
Clene to Present at the Jones Healthcare and Technology Innovation Conference
GlobeNewswire
·
April 1, 2025
SALT LAKE CITY, April 01, 2025 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary, Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on revolutionizing the …
منظمة التوعية بأمراض الأسبستوس (ADAO) تعلن عن "الأسبوع العالمي للتوعية بالأسبستوس" السنوي الـ21، من 1 إلى 7 أبريل
EIN Presswire
·
April 1, 2025
قيادة الجهود العالمية لزيادة الوعي والوقاية من التعرض للأسبستوس وحماية الصحة العامة من الأمراض المرتبطة به WASHINGTON, DC, UNITED STATES, March 31, 2025 /EINPresswire.com/ -- وهي أكبر منظمة غير ربحية مستقلة مقرها الولايات المتحدة مكرسة لمنع التعرّض …
Avalyn Completes Successful Phase 1 Clinical Trials of AP02, its Novel Inhaled Formulation of Nintedanib, Preparing for Phase 2 Development in Idiopathic Pulmonary Fibrosis
GlobeNewswire
·
April 1, 2025
Topline data from the single- and multiple-ascending dose studies confirmed safety and favorable tolerability profile of AP02 at all dose levels Full safety, tolerability, and pharmacokinetics data to be presented at the American Thoracic Society 2025 …
Qualigen seeks to enter the $10 Billion CABG market with non-binding MOU to acquire Marizyme
GlobeNewswire
·
April 1, 2025
CARLSBAD, Calif., April 01, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) announced today they have entered a non-binding Memorandum of Understanding (MOU) to acquire Marizyme (OTC: MRZM). Qualigen and Marizyme have …
Endeavour Silver Announces Expansion into Peru with Acquisition of Minera Kolpa, Copper Stream and Bought Deal Financing
GlobeNewswire
·
April 1, 2025
The Base Shelf Prospectus is accessible, and the Prospectus Supplement will be accessible within two business days, through SEDAR+ All dollar amounts are stated in United States (U.S.) Dollars unless otherwise noted. VANCOUVER, British Columbia, April 01, …
Medicenna to Present at Jones Healthcare and Technology Innovation Conference
GlobeNewswire
·
April 1, 2025
TORONTO and HOUSTON, April 01, 2025 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines targeting cancer and autoimmune …
Codexis Appoints Cynthia Collins to Board of Directors
GlobeNewswire
·
April 1, 2025
REDWOOD CITY, Calif., April 01, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the appointment of Cynthia Collins to the Company’s …
Purple Biotech to Participate in Panel Discussion at Canaccord Genuity Horizons in Oncology Virtual Conference on April 7, 2025
GlobeNewswire
·
April 1, 2025
REHOVOT, Israel, April 01, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance, …
BiomX Announces Compliance with NYSE Guidelines on Audit Opinion Disclosure
GlobeNewswire
·
April 1, 2025
NESS ZIONA, Israel, April 01, 2025 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, announced that, as …
Oculis to Host In-Person and Virtual R&D Day on Key Business Updates and the Development Plans for Privosegtor (OCS-05) in Acute Optic Neuritis and Beyond
GlobeNewswire
·
April 1, 2025
ZUG, Switzerland, April 01, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis” or the “Company"), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with significant …
Aura Reports Updated Mineral Reserves And Mineral Resources For The Year-Ended 2024, Highlighting Ongoing Exploration And Strong Growth Trajectory
GlobeNewswire
·
April 1, 2025
ROAD TOWN, British Virgin Islands, April 01, 2025 (GLOBE NEWSWIRE) -- Aura Minerals Inc. (TSX: ORA) (B3: AURA33) (OTCQX: ORAAF) (“Aura” or the “Company”) is pleased to report updated Mineral Reserves and Mineral Resources (“MRMR”) for its four operating …
Silynxcom Ltd. Announces Pricing of Public Offering
GlobeNewswire
·
April 1, 2025
New York, New York, March 31, 2025 (GLOBE NEWSWIRE) -- Silynxcom Ltd. (NYSE American: SYNX) (“Silynxcom” or the “Company”), a manufacturer and developer of ruggedized tactical communication headset devices as well as other communication accessories, today …